Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) EBT Margin (2018 - 2025)

Historic EBT Margin for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to 501.92%.

  • Bicycle Therapeutics' EBT Margin rose 15253600.0% to 501.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 4509.57%, marking a year-over-year increase of 73561200.0%. This contributed to the annual value of 14967.5% for FY2024, which is 115150500.0% down from last year.
  • Bicycle Therapeutics' EBT Margin amounted to 501.92% in Q3 2025, which was up 15253600.0% from 2711.75% recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' EBT Margin ranged from a high of 321.52% in Q4 2023 and a low of 2711.75% during Q2 2025
  • Over the past 5 years, Bicycle Therapeutics' median EBT Margin value was 619.84% (recorded in 2025), while the average stood at 802.09%.
  • In the last 5 years, Bicycle Therapeutics' EBT Margin surged by 20950300bps in 2022 and then crashed by -22876800bps in 2025.
  • Quarter analysis of 5 years shows Bicycle Therapeutics' EBT Margin stood at 2481.12% in 2021, then surged by 84bps to 386.1% in 2022, then surged by 183bps to 321.52% in 2023, then tumbled by -40bps to 193.47% in 2024, then plummeted by -359bps to 501.92% in 2025.
  • Its EBT Margin stands at 501.92% for Q3 2025, versus 2711.75% for Q2 2025 and 619.84% for Q1 2025.